Michael C. James, Director at GUIDED THERAPEUTICS INC (GTHP), bought 27,778 shares at $0.18 ($5K) on 2025-08-29, disclosed to the SEC on 2025-09-05.
Open-market purchase of $5k GTHP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| EDBL | BUY | 2022-09-16 | $880 | — | Filing → |
| EDBL | BUY | 2022-09-12 | $5K | — | Filing → |
| TRTC | SELL | 2017-11-17 | $110K | — | Filing → |